Daniel Marsh

Daniel Marsh

Senior Markets Analyst

Daniel Marsh is a senior markets analyst at StockTi with over 12 years of experience covering U.S. and global equity markets. He holds a CFA charter and previously worked as an equity research associate at a major Wall Street firm. Daniel specializes in macroeconomic analysis, market trends, and cross-sector investment themes. His work focuses on translating complex market data into actionable insights for individual and institutional investors.

Markets, Economy, Analysis 5,972 articles

Articles by Daniel Marsh

FTSE 100 Gains Concentrated in Two-Day Rally; Energy and Earnings in Focus
Markets

FTSE 100 Gains Concentrated in Two-Day Rally; Energy and Earnings in Focus

The FTSE 100 advanced 1.23% last week, but nearly all gains came from a two-day rally. Key earnings from BP, HSBC, and Glencore are due next week.

UL RR BP HSBC NXT USO
AI Cash Flow Concerns Split Tech Stocks as S&P 500 Gains 1.1%
Markets

AI Cash Flow Concerns Split Tech Stocks as S&P 500 Gains 1.1%

Wall Street ended higher last week, but AI investment scrutiny deepened. Microsoft and Amazon rallied on strong cloud results, while Apple and Meta slid on cash flow worries.

MSFT AMZN AAPL META PLTR AMD LLY
Global Markets Wrap: Barclays Surges, Yamanashi Split, Coldcard Breach
Markets

Global Markets Wrap: Barclays Surges, Yamanashi Split, Coldcard Breach

Barclays shares soar 442% from 2020 lows, Yamanashi Chuo Bank plans a stock split, and Coldcard bitcoin wallets suffer a $70M security breach.

BCS MSFT BRZE
Oracle Stock Surges 13% on Gemini Deal, Cloud Growth
Analysis

Oracle Stock Surges 13% on Gemini Deal, Cloud Growth

Oracle shares climbed 13% this week after announcing a Gemini AI partnership with Alphabet and reporting strong cloud growth. Backlog conversion covers 85% of its FY2027 revenue target.

ORCL GOOGL MSFT AMZN AMD
Inno Holdings Stock Plunges 54% on Share-Count Revision
Markets

Inno Holdings Stock Plunges 54% on Share-Count Revision

Inno Holdings shares plunged 54% after trading resumed, as a revised share count implies a $45M valuation, below its $60M ATM program ceiling.

INHD NDAQ
Replimune Surges 107% as FDA Panel Backs RP1 Despite Data Discrepancies
Analysis

Replimune Surges 107% as FDA Panel Backs RP1 Despite Data Discrepancies

Replimune shares soared 107% after an FDA panel endorsed RP1's efficacy data, despite conflicting response rates. The FDA decision is expected by August 2.

REPL BMY IOVA BMO
Integer Holdings Soars 20% on KKR Takeover Speculation
Markets

Integer Holdings Soars 20% on KKR Takeover Speculation

Integer Holdings jumped 20% on reports that KKR is in advanced talks to acquire the medical device maker for around $127 per share, leaving a narrow spread for investors.

ITGR KKR
WBD Stock Climbs 3.2% as Legal Hurdle to Paramount Deal Narrows
Markets

WBD Stock Climbs 3.2% as Legal Hurdle to Paramount Deal Narrows

WBD shares gained 3.2% Friday, closing at $26.29, as reports of a possible settlement in the Paramount antitrust lawsuit improved deal prospects.

WBD PSKY CMCSA DIS NFLX
Dow Rises 278 Points, But Rally Hinges on Just Two Stocks
Markets

Dow Rises 278 Points, But Rally Hinges on Just Two Stocks

The Dow rose 278 points Friday, but Amazon and Alphabet accounted for 124% of the gain. Apple and Boeing dragged, while the Nasdaq outperformed.

AMZN GOOGL AAPL BA CAT DIS NVDA
AI-Driven Rally Lifts S&P 500, But Small Caps Lag Behind
Markets

AI-Driven Rally Lifts S&P 500, But Small Caps Lag Behind

S&P 500 and Nasdaq rise on AI optimism, but small caps lag. Amazon surges 15% on strong AWS, Apple falls on weak outlook. Yields climb ahead of jobs data.

AMZN MSFT AAPL NVDA SPY QQQ IWM
Alibaba Surges 5% on AI Cloud Deal Report
Analysis

Alibaba Surges 5% on AI Cloud Deal Report

Alibaba (BABA) rose 5.1% to $122.28 after a report linked its cloud infrastructure to Moonshot AI's chip acquisition, highlighting AI-cloud synergy. The stock is up 9% in five days.

BABA JD PDD KWEB NVDA AMZN MSFT
AMC Stock Slips Despite Record Spider-Man Preview and Dilution Concerns
Markets

AMC Stock Slips Despite Record Spider-Man Preview and Dilution Concerns

AMC shares dipped to $2.76 despite a record $72M Spider-Man preview. A 74% increase in share count weighs on valuation.

AMC CNK IMAX NCMI